Andrew Hull

Insider Reports History

Entity
Individual
Location
C/O Inmed Pharmaceuticals Inc., Suite 310 815 Hastings Street, Vancouver, British Columbia, Canada
Signature
/s/ Eric A Adams, attorney-in-fact for Mr. Andrew Hull
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Hull:

Stock Role Class Num Shares Value Price $ Report Date Ownership
InMed Pharmaceuticals Inc. Director Common Stock 38.3K $14.9K $0.39 Feb 21, 2024 Direct
InMed Pharmaceuticals Inc. Director Employee Stock Option (Right to Buy) 8.58K Dec 23, 2023 Direct
InMed Pharmaceuticals Inc. Director Employee Stock Option (Expiration) 8.54K Jan 14, 2024 Direct
InMed Pharmaceuticals Inc. Director Employee Stock Option (Right to Buy) 977 Dec 20, 2024 Direct

Insider Reports Filed by Andrew Hull

Symbol Company Period Transactions Value $ Form Type Date Filed Role
INM InMed Pharmaceuticals Inc. Dec 20, 2024 1 $0 4 Dec 23, 2024 Director
INM InMed Pharmaceuticals Inc. Feb 21, 2024 1 $14.6K 4 Feb 22, 2024 Director
INM InMed Pharmaceuticals Inc. Jan 14, 2024 1 $0 4 Mar 5, 2024 Director
INM InMed Pharmaceuticals Inc. Dec 23, 2023 1 $0 4 Dec 26, 2023 Director
INM InMed Pharmaceuticals Inc. Dec 16, 2022 1 $0 4 Dec 19, 2022 Director
INM InMed Pharmaceuticals Inc. Jan 24, 2022 1 $0 4 Jan 24, 2022 Director
INM InMed Pharmaceuticals Inc. Dec 29, 2021 1 $0 4 Dec 30, 2021 Director